You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Kindstar has also agreed to purchase Genesis systems for use by its scientists to monitor circulating tumor cells and for single-cell research.
Contextual Genomics' recently launched assay screens for cell-free circulating tumor DNA in plasma to identify somatic genome alterations.
As part of the distribution agreement, Biolidics will distribute the IncellDx bioINK kit with Biolidics' ClearCell FX1 system.
Spartan's test is for the rapid, near-patient determination of a cardiac patient's genotype for aid in determining appropriate antiplatelet treatment.
Cardinal Health will offer the device as a standalone product to hospitals and as part of a customizable kit to address blood culture contamination.
The company signed a distribution agreement in Japan for its Idylla products and also initiated a listing of €150 million in unsecured convertible bonds.
The Unity test enables screening for several autosomal recessive conditions from fetal DNA gathered from maternal blood.
Mobidiag signed agreements for its Amplidiag and Novodiag products with Alab in Poland and the Ukraine; Biogenetix in Romania; and Theranostica in Israel.
Hardy Diagnostics has partnered with NG Biotech to exclusively distribute the 15-minute test in the US. It has also brought it through the US regulatory process.
The NG-Test Carba 5 detects and differentiates KPC, OXA-48-like, VIM, IMP, and NDM and provides results in 15 minutes.